Used in pharmaceutical research as a potent and selective inhibitor of soluble epoxide hydrolase (sEH), an enzyme involved in the metabolism of epoxy fatty acids. By inhibiting sEH, this compound helps maintain higher levels of endogenous epoxy fatty acids, which have anti-inflammatory, analgesic, and vasodilatory effects. It is investigated for potential therapeutic applications in pain management, inflammatory diseases, and cardiovascular conditions. Its structure allows for improved metabolic stability and bioavailability, making it a valuable candidate in preclinical studies for developing new treatments targeting chronic pain and neuroinflammation.